We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Teradata
TDC
$2.49B
| $5.68M | 0.03% |
+168,737
| New | +$5.43M |
|
602
Rhythm Pharmaceuticals
RYTM
$8.1B
| $5.68M | 0.03% |
194,996
-48,412
| -20% | -$1.24M |
|
603
Braze
BRZE
$3.12B
| $5.66M | 0.03% |
207,582
-53,125
| -20% | -$1.48M |
|
|
AGR
604
DELISTED
Avangrid, Inc.
AGR
| $5.66M | 0.03% |
131,618
+63,818
| +94% | +$2.64M |
|
605
Asana
ASAN
$2.07B
| $5.65M | 0.03% |
410,109
-1,098,261
| -73% | -$19.9M |
|
606
American Tower
AMT
$79.4B
| $5.6M | 0.03% |
26,434
-80,966
| -75% | -$16.9M |
|
607
Qualcomm
QCOM
$171B
| $5.59M | 0.03% |
+50,833
| New | +$5.95M |
|
608
Vicor
VICR
$10.4B
| $5.58M | 0.03% |
103,805
-4,774
| -4% | -$251K |
|
609
Arrowhead Research
ARWR
$12.3B
| $5.57M | 0.03% |
137,433
+60,279
| +78% | +$2M |
|
610
MP Materials
MP
$9.64B
| $5.55M | 0.03% |
228,464
+12,924
| +6% | +$392K |
|
|
CIM
611
Chimera Investment
CIM
$991M
| $5.53M | 0.03% |
335,227
-92,526
| -22% | -$1.73M |
|
612
Bruker
BRKR
$9.03B
| $5.47M | 0.03% |
79,977
-118,634
| -60% | -$7.54M |
|
613
J.M. Smucker
SJM
$12.7B
| $5.45M | 0.03% |
34,418
+29,085
| +545% | +$4.33M |
|
614
Sunstone Hotel Investors
SHO
$2.01B
| $5.45M | 0.03% |
563,813
+242,562
| +76% | +$2.51M |
|
615
Teekay Tankers
TNK
$2.81B
| $5.44M | 0.03% |
176,541
-13,299
| -7% | -$423K |
|
616
News Corp Class B
NWS
$17.7B
| $5.42M | 0.03% |
293,943
+27,887
| +10% | +$492K |
|
617
Federal Signal
FSS
$7.71B
| $5.41M | 0.03% |
116,451
+102,552
| +738% | +$4.71M |
|
618
Hawaiian Electric Industries
HE
$2.06B
| $5.4M | 0.03% |
129,076
-39,518
| -23% | -$1.53M |
|
619
Upbound Group
UPBD
$1.11B
| $5.39M | 0.03% |
238,915
-80,820
| -25% | -$1.73M |
|
620
Blackstone Mortgage Trust
BXMT
$2.41B
| $5.37M | 0.03% |
253,743
+49,642
| +24% | +$1.18M |
|
621
LiveRamp
RAMP
$2.3B
| $5.36M | 0.03% |
228,690
-147,439
| -39% | -$2.98M |
|
622
Fate Therapeutics
FATE
$317M
| $5.36M | 0.03% |
531,036
+8,462
| +2% | +$159K |
|
623
Acushnet Holdings
GOLF
$5.2B
| $5.34M | 0.03% |
125,873
+56,178
| +81% | +$2.53M |
|
624
uniQure
QURE
$3.13B
| $5.23M | 0.03% |
230,907
-18,432
| -7% | -$398K |
|
625
BioMarin Pharmaceuticals
BMRN
$13.6B
| $5.21M | 0.03% |
+50,336
| New | +$4.73M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.